Athena Countouriotis MD
University of California, Los Angeles
Tell me more about Athena Countouriotis MD?
Athena Countouriotis MD is a highly experienced professional with 18.1 years of work experience. She has a strong skill set in Microsoft Office, including Excel, Word, and PowerPoint. Currently, she serves as the President and Chief Executive Officer at Turning Point Therapeutics, where she has been leading development programs to approval. Athena has also led various clinical development organizations, including Adverum Biotechnologies and Halozyme Therapeutics. She holds a Bachelor of Science degree from the University of California, Los Angeles, and an M.D. from Tufts University School of Medicine.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
Athena Countouriotis became president and chief executive officer and was named to the Turning Point Therapeutics board of directors in September 2018. She has broad oncology biotech leadership experience, guiding multiple development programs to approval. Her experience includes large and small molecule therapeutics in hematologic and solid tumor indications, with multiple regulatory approvals in the U.S. and Europe. She joined Turning Point Therapeutics in May 2018 as executive vice president and chief medical officer to advance the clinical development of repotrectinib. She previously served as senior vice president and chief medical officer for Adverum Biotechnologies, and before that as senior vice president and chief medical officer of Halozyme Therapeutics. Athena Countouriotis also served as chief medical officer of Ambit Biosciences, where she helped lead the company’s initial public offering and was responsible for the clinical development of quizartinib until the company’s acquisition by Daiichi Sankyo in November 2014. Earlier in her career, Athena Countouriotis led various clinical development organizations within Pfizer and Bristol-Myers Squibb for oncology therapeutics including Sutent®, Mylotarg™, Bosulif® and Sprycel®. Athena Countouriotis also serves on the board of directors of Trovagene and NuMedii. She earned a Bachelor of Science degree from the University of California, Los Angeles, and an M.D. from Tufts University School of Medicine. She received her initial medical training in pediatrics at the University of California, Los Angeles, and additional training at the Fred Hutchinson Cancer Research Center in the Pediatric Hematology/Oncology Program.
...See MoreWork Experience
co founder chief executive officer avenzo therapeutics
Director Capstan Therapeutics
Biotechnology Research
Athena Countouriotis MD's Professional Milestones
- SVP Chief Medical Officer (2017-06-01~2018-05-01): Driving the development and implementation of cutting-edge medical strategies to streamline operations and improve patient outcomes.
- Chief Medical Officer (2012-02-01~2014-12-01): Revitalized medical service processes and achieved record-breaking revenue targets through strategic planning and effective team management.
Education
Physiology, General,
Bs
Skill
Microsoft Office
Microsoft Excel
Microsoft Word
Powerpoint
Customer Service
Research
Photoshop
English
Outlook
Windows
Teaching
Html
Certification
Colleagues
Gregor Adams
vp preclinical development at capstan therapeutics
Laura Shawver
President | Chief Executive Officer
Michelle Mazzoni, PhD, RAC (US, Can, EU)
Senior Vice President Regulatory And Quality
Justin Thacker
chief financial officer at capstan therapeutics
Adrian Bot, M.D., Ph.D.
chief scientific officer and executive vice president of r&d at capstan therapeutics
Other Named Athena Countouriotis MD
Frequently asked questions
We found 6 Athena Countouriotis MD's email addresses
Athena Countouriotis MD's social media include: Linkedin,
Athena Countouriotis MD works for Capstan Therapeutics
Athena Countouriotis MD's role in Capstan Therapeutics is co founder chief executive officer avenzo therapeutics
Athena Countouriotis MD works in the industry of Biotechnology Research
Athena Countouriotis MD's colleagues are Gregor Adams,Laura Shawver,Michelle Mazzoni, PhD, RAC (US, Can, EU)
Athena Countouriotis MD's latest job experience is co founder chief executive officer avenzo therapeutics at Capstan Therapeutics
Athena Countouriotis MD's latest education in University of California, Los Angeles